A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland

Ann Oncol. 2003 Aug;14(8):1327-8. doi: 10.1093/annonc/mdg331.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / radiotherapy
  • Adenocarcinoma / surgery
  • Aged
  • Androgen Antagonists / administration & dosage*
  • Anilides / administration & dosage*
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Humans
  • Male
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / pathology*
  • Nitriles
  • Parotid Gland / surgery
  • Parotid Neoplasms / radiotherapy
  • Parotid Neoplasms / surgery
  • Radiotherapy, Adjuvant
  • Receptors, Androgen / drug effects
  • Risk Assessment
  • Skin Ulcer / drug therapy
  • Skin Ulcer / pathology
  • Tosyl Compounds
  • Treatment Outcome
  • Triptorelin Pamoate / administration & dosage*

Substances

  • Androgen Antagonists
  • Anilides
  • Nitriles
  • Receptors, Androgen
  • Tosyl Compounds
  • Triptorelin Pamoate
  • bicalutamide